Gradually progress is being made in precision medicine in the non-oncology space. However, precision non-oncology faces a unique set of challenges.
Category: Forbes
Dairy Industry Trumps Infant Health With U.S. Rejection Of Breastfeeding Resolution
The administration’s refusal to support restrictions on formula marketing shows its willingness to prioritize industry economic interests over the health and wellbeing of children.
Amid Executive Shuffle, Anthem Looks To Expand Health Services
Anthem CEO Gail Boudreaux is dealing with executive departures while expanding into healthcare services, forming what some are calling a “mini Optum.”
‘Forest Bathing’ Really May Be Good For Health, Study Finds
The health craze in Japan and neighboring countries may well supported by science.
Eight Influential Tech Leaders Making A Difference
Council members name tech leaders that are changing the world.
Not All Drugs Are Created Equal – Purity And Potency Now Shaping The U.S. Drug Crisis
When it comes to the persistent conversations in the U.S. about the drug crisis, one conversation seems to be consistently overlooked. What substances are being used, and in what purity and potency. If purchased from an individual or unlicensed dispens…
Mexico Could Make History By Treating CBD Like A Supplement, As It Should Be
As Mexico pivots toward medical marijuana, certain rules could help make the non-intoxicating “miracle” compound as easy to buy as vitamins or minerals.
Theranos? Whatever. Healthcare Startups Have Raised $15 Billion So Far This Year
The total number of companies splitting that cash pile has dropped, from 855 in the first six months of 2017 to 779 in the first half of 2018, meaning investors have chosen to make bigger bets in a smaller number of companies.
Will The Cost of Health Care Devour Your Retirement Income?
Health Care in Retirement will cost more, likely way more than you can imagine. Medicare is not free, and does not cover all medical expenses. How to calculate what your health care in retirement may cost. Financial Planner explains so you can have…
Vivek Ramaswamy’s Enzyvant Asks FDA To Approve Treatment For Dying Babies
“At the end of the day the metric of our success as a business is going to be the number and quality of new medicines that we get approved by the FDA and regulators in other markets,” Ramaswamy said in an interview. “Everything else is just the means t…
